InvestorsObserver
×
News Home

Should Biotechnology Stock Brickell Biotech Inc (BBI) Be in Your Portfolio Wednesday?

Wednesday, July 06, 2022 09:59 AM | InvestorsObserver Analysts

Mentioned in this article

Should Biotechnology Stock Brickell Biotech Inc (BBI) Be in Your Portfolio Wednesday?

Brickell Biotech Inc (BBI) is near the bottom in its industry group according to InvestorsObserver. BBI gets an overall rating of 27. That means it scores higher than 27 percent of stocks. Brickell Biotech Inc gets a 10 rank in the Biotechnology industry. Biotechnology is number 27 out of 148 industries.

Overall Score - 27
BBI has an Overall Score of 27. Find out what this means to you and get the rest of the rankings on BBI!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 27 means the stock is more attractive than 27 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Brickell Biotech Inc Stock Today?

Brickell Biotech Inc (BBI) stock is trading at $3.73 as of 9:56 AM on Wednesday, Jul 6, a decline of -$0.25, or -6.28% from the previous closing price of $3.98. The stock has traded between $3.72 and $3.94 so far today. Volume today is low. So far 40,174 shares have traded compared to average volume of 250,462 shares. Click Here to get the full Stock Report for Brickell Biotech Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App